The Case for Adherent Early Adoption of EntrestoThe Case for Adherent Early Adoption of Entresto

Dr Seth Bilazarian respectfully disagrees with Dr John Mandrola and outlines why he will be a cautious and strictly adherent adopter of the new ARNI heart failure drug. theheart.org on Medscape
Source: theHeart.org - Category: Cardiology Tags: Cardiology Commentary Source Type: news